Lebanon, a country with advanced tertiary care referral centers, has the highest rate of prostate cancer in the region due to high use of PSA screening with 39.3 per 100,000 in most recent data in 2018 (Table 2). The gene discussed is KLK3; the disease is prostate cancer.